Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Releases 2014 Open Payments Data; Industry Payments To Docs Top $6.49 Billion

This article was originally published in The Gray Sheet

Executive Summary

Over 11.4 million financial transactions from device and drug firms to physicians in 2014 worth over $6.49 billion were reported to the Open Payments database, including individual royalties and consulting fees in the hundreds of thousands of dollars from orthopedic firms, according to CMS data.

You may also be interested in...



Top Ortho Firms Paid $516M To Physicians In 2022, Open Payments Data Shows

Analysis of Open Payments data compiled by CMS shows that Medtronic, Smith + Nephew, DePuy Synthes, Zimmer Biomet and Stryker paid a total of $516m to physicians in 2022. Top spending categories: Royalties, acquisitions and consulting fees.

Grassley Asks Price To Preserve 'Open Payments' Database

Sen. Chuck Grassley, R-Iowa, urged US Department of Health and Human Services secretary nominee Tom Price to preserve the "Open Payments" database that was established by Grassley's Physician Payment Sunshine Act, even if the Affordable Care Act, by which the Sunshine law was enacted, is repealed.

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel